- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01486420
Open Surgery Versus Corticosteroid Injections in Treatment of Trigger Finger
Open Surgery Versus Ultrasound Guided Local Corticosteroid Injections in Treatment of Trigger Finger - a Randomized Controlled Trial.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Silkeborg, Denmark, 8600
- Center for Planned surgery - Regionalhospital Silkeborg
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Trigger finger Quinell grade IIb-V in digit I-V
Exclusion Criteria:
- Former treatment of Trigger finger in affected digit
- Dupuytrens contracture in affected digit
- Allergies or intolerance to used medications
- Rheumatoid Arthritis
- Insulin dependent Diabetes Mellitus
- Amyloidosis
- Mucopolysaccharidosis
- Already included in study with another digit
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Open surgery
|
Open A1-pulley release
|
|
Active Comparator: Corticosteroid Injection
|
Corticosteroid injections in and around A1-pulley.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quinell grade
Time Frame: 12 months
|
Dicotomized outcome defined as +/- failure. Failure defined as Quinell grade equal to or above IIb. Quinell grade defined as: I Normal movement, IIa normal movement with pain/tenderness to A1-pulley, IIb anamnestic triggering but not evident at clinical exam, III triggering without locking, IV triggering with locking but actively correctable, V Locked digit, passive correctable only. |
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Numerical Rating Scale (NRS) score
Time Frame: 12 weeks
|
Pain following either procedure measured by NRS (score 0-10, 10 is severe pain)
|
12 weeks
|
|
infection
Time Frame: 12 weeks
|
Infection occurence following either procedure
|
12 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Jeppe Lange, M.D., Center for Planned surgery - Regionalhospital Silkeborg
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- M-20110157
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.